Chemoinformaics analysis of 4-METHYL-1-PROPAN-2-YLBICYCLO[3.1.0]HEX-3-ENE-2-CARBALDEHYDE
| Molecular Weight | 164.248 | nRot | 2 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 42 |
| Exact Molecular Weight | 164.12 | nRing | 2 |
| Solubility: LogS | -3.707 | nHRing | 0 |
| Solubility: LogP | 5.218 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.8407 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.258 |
| Synth | 5.996 |
| Natural Product Likeliness | 1.816 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.331 |
| HIA | 0.011 |
| CACO-2 | -5.388 |
| MDCK | 0.0000248 |
| BBB | 0.16 |
| PPB | 0.748825 |
| VDSS | 0.884 |
| FU | 0.217176 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.968 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.973 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.647 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.952 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.961 |
| CL | 8.338 |
| T12 | 0.289 |
| hERG | 0.98 |
| Ames | 0.079 |
| ROA | 0.419 |
| SkinSen | 0.923 |
| Carcinogencity | 0.028 |
| EI | 0.004 |
| Respiratory | 0.519 |
| NR-Aromatase | 0.35 |
| Antiviral | No |
| Prediction | 0.797275 |